Royalty Pharma Lobs $6.6B Takeover Bid At Elan
Pharmaceutical investment firm Royalty Pharma LLC has offered $6.6 billion to take over Elan Corp., it said Monday, a proposal that comes after Elan earlier this month agreed to sell a...To view the full article, register now.
Already a subscriber? Click here to view full article